Pamidronate alters the growth plate in the oim mouse model for osteogenesis imperfecta.

about

Bulbous epiphysis and popcorn calcification as related to growth plate differentiation in osteogenesis imperfecta Low dose of bisphosphonate enhances sclerostin antibody-induced trabecular bone mass gains in Brtl/+ osteogenesis imperfecta mouse model.

P2860

Q36223620-EAA3BEA8-E9A7-4C11-BDE7-3C977B8C57AE Q52653933-177659C6-6EB8-4684-AE92-5A639A49ABA8

P2860

Pamidronate alters the growth plate in the oim mouse model for osteogenesis imperfecta.

Item

http://www.wikidata.org/entity/Q36735620

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Pamidronate alters the growth plate in the oim mouse model for osteogenesis imperfecta.

@ast

Pamidronate alters the growth plate in the oim mouse model for osteogenesis imperfecta.

@en

type

Item

label

Pamidronate alters the growth plate in the oim mouse model for osteogenesis imperfecta.

@ast

Pamidronate alters the growth plate in the oim mouse model for osteogenesis imperfecta.

@en

prefLabel

Pamidronate alters the growth plate in the oim mouse model for osteogenesis imperfecta.

@ast

Pamidronate alters the growth plate in the oim mouse model for osteogenesis imperfecta.

@en

P1476

Pamidronate alters the growth plate in the oim mouse model for osteogenesis imperfecta.

@en

P2093

A M Oberbauer

http://www.w3.org/2001/XMLSchema#string

K D Evans

http://www.w3.org/2001/XMLSchema#string

L E Sheppard

http://www.w3.org/2001/XMLSchema#string

R B Martin

http://www.w3.org/2001/XMLSchema#string

S H Rao

http://www.w3.org/2001/XMLSchema#string

P2860

Normative data for iliac bone histomorphometry in growing children.

Treatment of osteoporosis with bisphosphonates.

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta.

Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling.

Radiographic features of bisphosphonate therapy in pediatric patients.

Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta.

Tracing the pathway between mutation and phenotype in osteogenesis imperfecta: isolation of mineralization-specific genes.

Bisphosphonate treatment in the oim mouse model alters bone modeling during growth

Long Term Cyclic Pamidronate Reduces Bone Growth by Inhibiting Osteoclast Mediated Cartilage-to-Bone Turnover in the Mouse.

Clinical review 1: Bisphosphonate use in childhood osteoporosis.

P304

345-352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23675157

http://www.w3.org/2001/XMLSchema#string

P921

osteogenesis imperfecta

P932

3614807

http://www.w3.org/2001/XMLSchema#string

Pamidronate alters the growth plate in the oim mouse model for osteogenesis imperfecta.

about

P2860

P2860

Pamidronate alters the growth plate in the oim mouse model for osteogenesis imperfecta.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932